Supplementary Figure 2: Production, purification, and sequencing of a 205 nt oligo. (A)
Denatured PAGE of the oligo_205 purified from cell culture under conditions removing the HTBS (RNase, no salt). The red band represents the band cut, purified, PCR, and sequenced. (B) The purified oligo_205 was recovered by PCR using primers 1 and 2 (red, PCR I) and run in a 1% agarose gel. A band around 200 bp was observed, confirming the correct size of the in vivo-produced oligo. As a control experiment, another PCR reaction was run with primers 1 and 2 while exchanging oligo205 with the plasmid pO_205 (this plasmid includes the identical DNA sequence as oligo_205). An identical PCR product was generated and visualized in the 1% agarose gel. An additional control experiment was run while both the oligo_205 and plasmid pO_205 were PCR with primers 3 and 4 (PCR II). These reactions should enable a 1.8 kbp PCR product only in the presence of pO205 plasmid. As expected, no PCR product was detected using oligo205 as the template, confirming that the purified oligo_205 sample does not contain plasmid contamination. (C) Sequencing analysis of the oligo_205 compared to its predicted sequence.
Supplementary Figure 3:
Characterization of an in vivo produced 49 nt oligo. Denatured PAGE of a 49-nt in vivo ssDNA product compared with industrial chemically synthesized ssDNA is shown. The ladder was calculated using commercial oligos run in the same gel. The 49-nt in vivo ssDNA was further used for the assembly of the 2D arrays shown in Figure 4b , the +-IPTG experiments were performed on different days from the DNAse control (experiments shown here). This figure shows the full gels before and after the addition of DNAse. The production of the DNA nanostructures are shown when different combinations of r_oligo genes are expressed in the presence of IPTG (+IPTG, 1 mM) under purifications conditions preserving the HTBS.
Supplementary Figure 8:
Detailed AFM images of the 4-part DNA nanostructures. These images and those used to make Figure 4 were performed on different days from different starting cultures. The top panel shows large scale AFM image (1.6 µm). The bottom magnifies zoom into specific structures (scale bar equal 50 nm). Letters correspond to regions within the larger image (no letter indicates that the detailed images were recorded from other AFM images). The experiments were performed with AFM tips (Model NSC11, Umasch, USA) and using tapping mode at their resonance frequency. The images were analyzed using NANO Scope analyzing software (Vecco, USA).
Supplementary Figure 9:
HIVRT control experiment for the 4-part DNA nanostructure. Data for the 4-part system lacking the HIVRT gene were generated under same condition to the 4-part system expressing the DNA nanostructure shown in Figure 4 . As expected, no bands are detected and no ssDNA are expressed in the absence of the HIVRT gene. Figure 5b . The 4-part DNA nanostructure includes eight 10-bp binding domains that connect the four ssDNA strands (ssDNA1-ssDNA4). One of the 10-bp domain forms the Zif268 zinc finger sequence through the hybridization of ssDNA1 with ssDNA4 (9 bp, red). Another 10-bp domain forms the PBSII zinc finger sequence through the hybridization of ssDNA2 with ssDNA3 (9 bp, blue). To complete a single turn helix, a single base pair (black) was added to both of these domains. In parallel to the expression of the different ssDNAs, two split-YFP proteins (nYFP and cYFP) linked to zinc finger proteins (nYFP with PBSII and cYFP with Zif268) were co-expressed. Controls were performed, including the expression of the 4-part system in the absence of HIVRT and those lacking different ssDNAs. Finally, 4-bp mutations to zif268 and 5-bp mutations to PBSII (colored black in the 4-part_ZF_Mutant structure) were added to the two zinc finger domains, and this eliminated fluorescense. The histogram of the 4-part system lacking the split-YFP genes (4-part_-sliptYFPs) is also shown. The ssDNA sequences are provided in Supplementary Table 2.
Supplementary Figure 10 (next page): Expanded schematics and cytometry data corresponding to

Supplementary Figure 11:
Control experiment of the the 4-part system compared with a linear plasmid used to reconstitute YFP. (a) Schematic for the different systems investigated to confirm that reconstitution of the YFP is only due to the 4-part assembly and not to a linear plasmid that includes the ZF sequences 3 . Each system includes a plasmid with a different combination of the ZF domains and at different distances from each other: : i) a single ZF domain, ii) two ZF domains at a long distance from each other (1426 and 2007 bp), iii) the two ZF domain at a close distance from each other (2bp), iv) the 4-part oligo plasmid that includes the two ZF domains at a long distance from each other (1426 and 2007 bp). As previously demonstrated 4 , a linear plasmid that includes the two ZF domains at a short distance (2 bp) may be used to reconstitute YFP (iii). Thus, the 4-part oligo plasmid has been designed in such a way that the two different ZF domains are located at a long distance from each other (1426 and 2007 bp), thus preventing the reconstitution of YFP (iv). (b) Increase in fluorescence over time is shown for the different systems shown in a. These data demonstrate that the plasmids with one or more ZF domains at a long distance do not reconstitute YFP (i+ii). In addition, the production of the 4-part DNA nanostructure (iv) reconstitutes 2-3 times more YFP compared with a linear plasmid that includes the ZF domains in close proximity (iii). Data shown represent the averages of three independent experiments performed on different days. Note that all the experiments were performed in the presence of the HIVRT plasmid (pHIV_pTp66p51) and the MLRT-split YFPs plasmid (pMLRT_sYFP) to maintain the identical 4-part DNA nanostructure in vivo sensor conditions (Methods). DNA constructs. All DNA sequences are provided as Supplementary Table 2 and key constructs will be made available via Addgene. The HIVRT p66 domain was codon optimized for E. coli and synthesized (Geneart). The p51 domain was obtained by PCR as a truncated version of this gene. The murine leukemia reverse transcriptase gene is not codon optimized and was received as a gift from Prof. Timothy Lu (MIT). The HTBS part was ordered as a Gblock (IDT). The assembly of r_oligo genes into different versions of the p_O_# plasmids was performed using the Golden Gate Method 2 . Plasmid maps are provided in the supplementary Fig. 15-24 . The 10bp sticky regions used for the ssDNAs to build the 4-part nanostructure were designed in the following way. The starting sequence was obtained from the original paper describing the crossover motif 3 . From this starting point, the zinc-finger sequences 4 were incorporated with random nucleotides selected by eye and changed to G or C in order to decrease the hybridization free energy. Each new sequence was tested for secondary structure using NuPack 5 and the IDT oligo analyzer software 6 and problematic sequences were mutated and retested. Using the same software, sequences were analyzed for the possibility to self-dimerize or form undesired hybridization products and potential problems were alleviated by making additional mutations.
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